Your browser doesn't support javascript.
loading
Tumor necrosis factor receptor-1 is selectively sequestered into Schwann cell extracellular vesicles where it functions as a TNFα decoy.
Sadri, Mahrou; Hirosawa, Naoya; Le, Jasmine; Romero, Haylie; Martellucci, Stefano; Kwon, Hyo Jun; Pizzo, Donald; Ohtori, Seiji; Gonias, Steven L; Campana, Wendy M.
Afiliação
  • Sadri M; Department of Anesthesiology, University of California, San Diego, La Jolla, California, USA.
  • Hirosawa N; Department of Anesthesiology, University of California, San Diego, La Jolla, California, USA.
  • Le J; Department of Orthopaedic Surgery and Graduate School in Medicine, Chiba University, Chiba, Japan.
  • Romero H; Department of Anesthesiology, University of California, San Diego, La Jolla, California, USA.
  • Martellucci S; Veterans Administration San Diego Healthcare System, San Diego, California, USA.
  • Kwon HJ; Department of Anesthesiology, University of California, San Diego, La Jolla, California, USA.
  • Pizzo D; Program in Neuroscience, University of California, San Diego, La Jolla, California, USA.
  • Ohtori S; Department of Anesthesiology, University of California, San Diego, La Jolla, California, USA.
  • Gonias SL; Department of Anesthesiology, University of California, San Diego, La Jolla, California, USA.
  • Campana WM; Department of Pathology, University of California, San Diego, California, USA.
Glia ; 70(2): 256-272, 2022 02.
Article em En | MEDLINE | ID: mdl-34559433
Schwann cells (SCs) are known to produce extracellular vesicles (EV) that participate in cell-cell communication by transferring cargo to target cells, including mRNAs, microRNAs, and biologically active proteins. Herein, we report a novel mechanism whereby SC EVs may regulate PNS physiology, especially in injury, by controlling the activity of TNFα. SCs actively sequester tumor necrosis factor receptor-1 (TNFR1) into EVs at high density, accounting for about 2% of the total protein in SC EVs (~1000 copies TNFR1/EV). Although TNFR2 was robustly expressed by SCs in culture, TNFR2 was excluded from SC EVs. SC EV TNFR1 bound TNFα, decreasing the concentration of free TNFα available to bind to cells and thus served as a TNFα decoy. SC EV TNFR1 significantly inhibited TNFα-induced p38 MAPK phosphorylation in cultured SCs. When TNFR1 was proteolytically removed from SC EVs using tumor necrosis factor-α converting enzyme (TACE) or neutralized with antibody, the ability of TNFα to activate p38 MAPK in the presence of these EVs was restored. As further evidence of its decoy activity, SC EV TNFR1 modified TNFα activities in vitro including: (1) regulation of expression of other cytokines; (2) effects on SC morphology; and (3) effects on SC viability. SC EVs also modified the effects of TNFα on sciatic nerve morphology and neuropathic pain-related behavior in vivo. By sequestering TNFR1 in EVs, SCs may buffer against the potentially toxic effects of TNFα. SC EVs provide a novel mechanism for the spatial and temporal regulation of neuro-inflammation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células de Schwann / Fator de Necrose Tumoral alfa / Receptores Tipo I de Fatores de Necrose Tumoral / Vesículas Extracelulares Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células de Schwann / Fator de Necrose Tumoral alfa / Receptores Tipo I de Fatores de Necrose Tumoral / Vesículas Extracelulares Idioma: En Ano de publicação: 2022 Tipo de documento: Article